Krejcí E - Search Results

1

Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patients.

Boudny V, Dusek L, Adámková L, Chumchalová J, Kocak I, Fait V, Lauerová L, Krejcí E, Kovarík J. Boudny V, et al. Among authors: krejci e. Neoplasma. 2005;52(4):330-7. Neoplasma. 2005. PMID: 16059651

2

Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein.

Humpoliková-Adámková L, Kovařík J, Dušek L, Lauerová L, Boudný V, Fait V, Fojtová M, Krejčí E, Kovařík A. Humpoliková-Adámková L, et al. Among authors: krejci e. Eur J Cancer. 2009 May;45(7):1315-1323. doi: 10.1016/j.ejca.2009.01.009. Epub 2009 Feb 14. Eur J Cancer. 2009. PMID: 19232485

3

Reduced inducibility of SOCS3 by interferon gamma associates with higher resistance of human breast cancer lines as compared to normal mammary epithelial cells.

Souckova K, Kovarik A, Dusek L, Humpolikova-Adamkova L, Lauerova L, Krejci E, Matouskova E, Bursikova E, Fojtova M, Kovarik J. Souckova K, et al. Among authors: krejci e. Neoplasma. 2009;56(5):379-86. doi: 10.4149/neo_2009_05_379. Neoplasma. 2009. PMID: 19580338

4

Defective IFNα/γ-induced STAT3 protein activation in human malignant melanoma cells.

Boudny V, Adamkova L, Souckova K, Lauerova L, Krejci E, Fait V. Boudny V, et al. Among authors: krejci e. Mol Med Rep. 2008 Nov-Dec;1(6):909-15. doi: 10.3892/mmr_00000049. Mol Med Rep. 2008. PMID: 21479505

5

Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma.

Kocakova I, Svoboda M, Kubosova K, Chrenko V, Roubalova E, Krejci E, Sefr R, Slampa P, Frgala T, Zaloudik J. Kocakova I, et al. Among authors: krejci e. Neoplasma. 2007;54(5):447-53. Neoplasma. 2007. PMID: 17688376

6

Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours.

Kocakova I, Kocak I, Spelda S, Krejci E, Bencsikova B, Jureckova A, Vyzula R, Bortlicek Z, Strenkova J, Brabec P. Kocakova I, et al. Among authors: krejci e. Bratisl Lek Listy. 2015;116(4):218-21. doi: 10.4149/bll_2015_042. Bratisl Lek Listy. 2015. PMID: 25773947

7

Cultivation-dependent plasticity of melanoma phenotype.

Kodet O, Dvořánková B, Krejčí E, Szabo P, Dvořák P, Štork J, Krajsová I, Dundr P, Smetana K Jr, Lacina L. Kodet O, et al. Among authors: krejci e. Tumour Biol. 2013 Dec;34(6):3345-55. doi: 10.1007/s13277-013-0905-x. Epub 2013 Jun 12. Tumour Biol. 2013. PMID: 23757003

8

Intercellular crosstalk in human malignant melanoma.

Dvořánková B, Szabo P, Kodet O, Strnad H, Kolář M, Lacina L, Krejčí E, Naňka O, Šedo A, Smetana K Jr. Dvořánková B, et al. Among authors: krejci e. Protoplasma. 2017 May;254(3):1143-1150. doi: 10.1007/s00709-016-1038-z. Epub 2016 Nov 3. Protoplasma. 2017. PMID: 27807664 Review.

9

Melanoma cells influence the differentiation pattern of human epidermal keratinocytes.

Kodet O, Lacina L, Krejčí E, Dvořánková B, Grim M, Štork J, Kodetová D, Vlček Č, Šáchová J, Kolář M, Strnad H, Smetana K. Kodet O, et al. Among authors: krejci e. Mol Cancer. 2015 Jan 5;14(1):1. doi: 10.1186/1476-4598-14-1. Mol Cancer. 2015. PMID: 25560632 Free PMC article.

10

Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.

Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P, Machackova E. Foretova L, et al. Among authors: krejci e. Klin Onkol. 2010;23(6):388-400. Klin Onkol. 2010. PMID: 21348412 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters